Increased myogenic potential and fusion of matrilysin-expressing myoblasts transplanted in mice.
The success of myoblast transplantation in clinical trials has been limited in part by the low dispersion of grafted cells outside the injection site. Our research group previously reported that the culture of myoblasts with concanavalin A, a stimulator of metalloproteinase production, increased their migration. Several lines of evidence also suggested that muscle cell fusion involves metalloproteinase-sensitive mechanisms. To determine whether the increased expression of metalloproteinases had an influence on myoblast fusion and dispersion through the muscle following transplantation, we generated a myoblast cell line expressing human matrilysin (MMP-7). The MMP-7-expressing myoblasts were obtained by the stable transfection of a matrilysin expression vector in a TnILacZ immortomouse myoblast clone. Matrilysin-expressing myoblasts showed a highly increased in vitro fusion index, forming seven times (p < 0.001) more myotubes than the control cell line and three times (p < 0.001) more myotubes than the Immortomyoblast parental clone. Single-site transplantation of matrilysin-expressing myoblasts generated more fibers (p < 0.001), over a greater surface (p < 0.001) than the control cell line. The cotransplantation of matrilysin-expressing myoblasts and of normal human myoblasts in SCID mice increased the number of human dystrophin-positive fibers and myotubes by sixfold. Although no significant increased migration of myoblasts outside the injection sites was observed, our results show that the metalloproteinase activity can improve the myogenic potential of myoblasts in vitro and the fusion of myoblasts with host fibers in vivo. MMP-7 expression may be useful in increasing myoblast transplantation success.
Caron
N J
NJ
Laboratoire de Génétique Humaine, Centre de Recherche du Centre Hospitalier de l'Université Laval, Université Laval, Ste-Foy, Qc, Canada.
Asselin
I
I
Morel
G
G
Tremblay
J P
JP
D000818:Animals; D002460:Cell Line; D017690:Cell Transplantation / Q000379:methods*; D002478:Cells, Cultured; D016189:Dystrophin / Q000096:biosynthesis / Q000235:genetics; D005260:Female; D006801:Humans; D020783:Matrix Metalloproteinase 7 / Q000096:biosynthesis / Q000235:genetics*; D051379:Mice; D008807:Mice, Inbred BALB C; D016513:Mice, SCID; D018482:Muscle, Skeletal / Q000166:cytology* / Q000378:metabolism; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D001616:beta-Galactosidase / Q000032:analysis / Q000235:genetics
D016189:Dystrophin; D011994:Recombinant Proteins; D001616:beta-Galactosidase; D020783:Matrix Metalloproteinase 7